Astronautx

Astronautx company information, Employees & Contact Information

Explore related pages

Related company profiles:

AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease.

Company Details

Employees
15
Founded
-
Address
330 High Holborn, Holborn Gate,united Kingdom
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Oxford.
HQ
London
Looking for a particular Astronautx employee's phone or email?

Astronautx Questions

News

Exclusive: Ascidian CEO Michael Ehlers leaves Apple Tree Partners for MPM BioImpact - Endpoints News

Exclusive: Ascidian CEO Michael Ehlers leaves Apple Tree Partners for MPM BioImpact Endpoints News

Novartis-backed AstronauTx heads off for Alzheimer's mission with $61M series A - Fierce Biotech

Novartis-backed AstronauTx heads off for Alzheimer's mission with $61M series A Fierce Biotech

Saniona's CEO comments on the collaboration with AstronauTx - Biostock

Saniona's CEO comments on the collaboration with AstronauTx Biostock

UCL spinout AstronauTx raises £48m funding to create new Alzheimer’s treatments | UCL News - UCL - University College London

UCL spinout AstronauTx raises £48m funding to create new Alzheimer’s treatments | UCL News - UCL University College London

Brandon Capital Joins AstronauTx’ £48 million ($61 million) Series A Financing to Create New Treatments for Alzheimer’s disease - Yahoo Finance

Brandon Capital Joins AstronauTx’ £48 million ($61 million) Series A Financing to Create New Treatments for Alzheimer’s disease Yahoo Finance

AstronauTx raises £48m in ‘Series A’ financing to create new treatments for Alzheimer’s - UK DRI

AstronauTx raises £48m in ‘Series A’ financing to create new treatments for Alzheimer’s UK DRI

This Biotech Fights Alzheimer’s Disease by Targeting Support Brain Cells - Labiotech.eu

This Biotech Fights Alzheimer’s Disease by Targeting Support Brain Cells Labiotech.eu

AstronauTx secures £6.5 million investment for new approach to dementia therapeutics - Alzheimer's Research UK

AstronauTx secures £6.5 million investment for new approach to dementia therapeutics Alzheimer's Research UK

IGM names Mary Beth Harler CEO as it prioritizes T cell engagers - BioCentury

IGM names Mary Beth Harler CEO as it prioritizes T cell engagers BioCentury

UK: AstronauTx appoints Jane Rhodes as CEO - Investors in Healthcare

UK: AstronauTx appoints Jane Rhodes as CEO Investors in Healthcare

Big Pharma Giants Back Revolutionary Biotech Startup AstronauTx’s in $61 Million Funding Round - BioTecNika

Big Pharma Giants Back Revolutionary Biotech Startup AstronauTx’s in $61 Million Funding Round BioTecNika

AstronauTx, funded by UCL DDI has received £48 million to develop Alzheimer's treatments - Alzheimer's Research UK

AstronauTx, funded by UCL DDI has received £48 million to develop Alzheimer's treatments Alzheimer's Research UK

Saniona’s CEO: ”The deal with Acadia is significant” - Biostock

Saniona’s CEO: ”The deal with Acadia is significant” Biostock

Top Astronautx Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant